SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-19-012979
Filing Date
2019-01-18
Accepted
2019-01-18 16:59:07
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 d693789d424b5.htm 424B5 297286
2 GRAPHIC g693789g33q91.jpg GRAPHIC 41162
  Complete submission text file 0001193125-19-012979.txt   355189
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-228581 | Film No.: 19533693
SIC: 3826 Laboratory Analytical Instruments
Assistant Director 10